Abiopharma

🔍 Munch Mark (Executive)

Company: BRUKER CORP (BRKR)

Report Date: 2026-01-12

Detailed Transactions and Holdings:

• Acquired 7,000 shares of Common Stock at $22.19 per share (Direct)
  Date: 2026-01-12 | Code: M | equity_swap_involved: 0 | shares_owned_after: 135,443.00 | transaction_form_type: 4
• Sold 7,000 shares of Common Stock at $55.0 per share (Direct)
  Date: 2026-01-12 | Code: S | equity_swap_involved: 0 | shares_owned_after: 128,443.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 7,000 shares of Stock Option (Right to Purchase) at $22.19 per share (Derivative)
  Date: 2026-01-12 | Code: M | Expires: 2026-10-04 | equity_swap_involved: 0 | shares_owned_after: 18,000.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
• F2: The stock option granted to the Reporting Person on October 4, 2016 (the "Original Grant Date") vests on the first, second, third and fourth anniversaries of the Original Grant Date.